Identification of Genetic Mutations in Cancer: Challenge and Opportunity in the New Era of Targeted Therapy
The introduction of targeted therapy is the biggest success in the treatment of cancer in the past few decades. However, heterogeneous cancer is characterized by diverse molecular alterations as well as multiple clinical profiles. Specific genetic mutations in cancer therapy targets may increase dru...
Main Authors: | Jing Jin, Xu Wu, Jianhua Yin, Mingxing Li, Jing Shen, Jing Li, Yueshui Zhao, Qijie Zhao, Jingbo Wu, Qinglian Wen, Chi Hin Cho, Tao Yi, Zhangang Xiao, Liping Qu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00263/full |
Similar Items
-
Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons
by: Qijie Zhao, et al.
Published: (2021-03-01) -
Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation
by: Zhu Wang, et al.
Published: (2019-03-01) -
Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
by: Shixin Xiang, et al.
Published: (2021-04-01) -
m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer
by: Yueshui Zhao, et al.
Published: (2019-10-01) -
Non-Small Cell Lung Cancer Treatment with Molecularly Targeted Therapy and Concurrent Radiotherapy—A Review
by: Katarzyna Król, et al.
Published: (2023-03-01)